126 related articles for article (PubMed ID: 3966920)
1. Inactivation by acivicin of carbamoyl-phosphate synthetase II of human colon carcinoma.
Sebolt JS; Aoki T; Eble JN; Glover JL; Weber G
Biochem Pharmacol; 1985 Jan; 34(1):97-100. PubMed ID: 3966920
[TBL] [Abstract][Full Text] [Related]
2. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
Aoki T; Sebolt J; Weber G
Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Crithidia fasciculata carbamoyl phosphate synthetase II by the antitumor drug acivicin.
Aoki T; Oya H
Mol Biochem Parasitol; 1987 Mar; 23(2):173-81. PubMed ID: 3574357
[TBL] [Abstract][Full Text] [Related]
4. Rapid in vivo inactivation by acivicin of CTP synthetase, carbamoyl-phosphate synthetase II, and amidophosphoribosyltransferase in hepatoma.
Denton JE; Lui MS; Aoki T; Sebolt J; Weber G
Life Sci; 1982 Mar; 30(13):1073-80. PubMed ID: 7078346
[TBL] [Abstract][Full Text] [Related]
5. Acivicin inhibits Crithidia fasciculata growth in a serum-free medium and inactivates carbamoyl-phosphate synthetase II in vivo.
Aoki T; Oya H
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):391-6. PubMed ID: 2902999
[TBL] [Abstract][Full Text] [Related]
6. Combined action of acivicin and D-galactosamine on pyrimidine nucleotide metabolism in hepatoma cells.
Leube K; Keppler DO
Biochem Pharmacol; 1983 Jun; 32(12):1865-9. PubMed ID: 6882463
[TBL] [Abstract][Full Text] [Related]
7. In vivo inactivation of formylglycinamidine ribonucleotide synthetase in rat hepatoma.
Elliott WL; Weber G
Biochem Pharmacol; 1985 Jan; 34(2):243-8. PubMed ID: 3966925
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
Jayaram HN; Ardalan B; Deas M; Johnson RK
Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
[TBL] [Abstract][Full Text] [Related]
9. Glutamine- and N-acetyl-L-glutamate-dependent carbamoyl phosphate synthetase from Micropterus salmoides. Purification, properties, and inhibition by glutamine analogs.
Casey CA; Anderson PM
J Biol Chem; 1983 Jul; 258(14):8723-32. PubMed ID: 6602805
[TBL] [Abstract][Full Text] [Related]
10. Effects of acivicin and PALA, singly and in combination, on de novo pyrimidine biosynthesis.
Kensler TW; Jayaram HN; Cooney DA
Adv Enzyme Regul; 1982; 20():57-73. PubMed ID: 7113804
[TBL] [Abstract][Full Text] [Related]
11. Biochemical pharmacology of acivicin in rat hepatoma cells.
Lui MS; Kizaki H; Weber G
Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
[TBL] [Abstract][Full Text] [Related]
12. Regulatory properties and behavior of activity of carbamoyl phosphate synthetase II (glutamine-hydrolyzing) in normal and proliferating tissues.
Aoki T; Morris HP; Weber G
J Biol Chem; 1982 Jan; 257(1):432-8. PubMed ID: 7053379
[TBL] [Abstract][Full Text] [Related]
13. The glutamine analog acivicin as antipyrimidine. Studies on the interrelationship between pyrimidine and urea synthesis in liver.
Pausch J; Rasenack J; Häussinger D; Holstege A; Gerok W
Adv Enzyme Regul; 1985; 24():233-43. PubMed ID: 3835821
[TBL] [Abstract][Full Text] [Related]
14. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
[TBL] [Abstract][Full Text] [Related]
15. Monocytoid differentiation of freshly isolated human myeloid leukemia cells and HL-60 cells induced by the glutamine antagonist acivicin.
Nichols KE; Chitneni SR; Moore JO; Weinberg JB
Blood; 1989 Oct; 74(5):1728-37. PubMed ID: 2790198
[TBL] [Abstract][Full Text] [Related]
16. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
[TBL] [Abstract][Full Text] [Related]
17. Enzymic programs of rat bone marrow and the impact of acivicin and tiazofurin.
Prajda N; Natsumeda Y; Ikegami T; Reardon MA; Szondy S; Hashimoto Y; Emrani J; Weber G
Biochem Pharmacol; 1988 Mar; 37(5):875-80. PubMed ID: 3345200
[TBL] [Abstract][Full Text] [Related]
18. Organisation and sequence determination of glutamine-dependent carbamoyl phosphate synthetase II in Toxoplasma gondii.
Fox BA; Bzik DJ
Int J Parasitol; 2003 Jan; 33(1):89-96. PubMed ID: 12547350
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of the amidotransferase activity of carbamoyl phosphate synthetase by the antibiotic acivicin.
Miles BW; Thoden JB; Holden HM; Raushel FM
J Biol Chem; 2002 Feb; 277(6):4368-73. PubMed ID: 11729189
[TBL] [Abstract][Full Text] [Related]
20. Radiometric enzyme-inhibition technique for measuring acivicin in plasma.
Jayaram HN; Kensler TW; Ardalan B
Cancer Treat Rep; 1981; 65(5-6):491-4. PubMed ID: 7237469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]